-
Founded in:
2004-01-12 -
Country:
China -
Address:
Binxi Economic and Technological Development Zone, Binxi Town, Bin County, Harbin -
Tax NO.:
912301257660088580 -
Registered Funds:
8.9 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| COPTIDISRHIZOMA |
|
0 | ||
| Chrysophanic acid |
|
481-74-3 | 0 | |
| RADIX SCUTELLARIAE |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| FOLIUM SYRINGAE |
Antibacterial and improve immune function; has a strong inhibitory and killing effect on 22 pathogens such as Staphylococcus aureus, Pneumococcus, Pseudomonas aeruginosa, Shigella dysenteriae, etc.; can significantly increase the spleen-specific antibody-forming cells of mice and stimulate beta cell proliferation; can also significantly reduce myocardial contractility and blood pressure, and reduce myocardial oxygen consumption.
More
Antibacterial and improve immune function; has a strong inhibitory and killing effect on 22 pathogens such as Staphylococcus aureus, Pneumococcus, Pseudomonas aeruginosa, Shigella dysenteriae, etc.; can significantly increase the spleen-specific antibody-forming cells of mice and stimulate beta cell proliferation; can also significantly reduce myocardial contractility and blood pressure, and reduce myocardial oxygen consumption. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Roxithromycin |
This product is a semi-synthetic 14-membered macrolide antibiotic. Its antibacterial spectrum and antibacterial effect are basically similar to those of erythromycin. It is slightly less effective than erythromycin against Gram-positive bacteria, but stronger than erythromycin against Legionella pneumophila. Its antimicrobial effect against Chlamydia pneumoniae, Mycoplasma pneumoniae, and Ureaplasma urealyticum is similar to or slightly stronger than that of erythromycin. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the transfer of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.
More
This product is a semi-synthetic 14-membered macrolide antibiotic. Its antibacterial spectrum and antibacterial effect are basically similar to those of erythromycin. It is slightly less effective than erythromycin against Gram-positive bacteria, but stronger than erythromycin against Legionella pneumophila. Its antimicrobial effect against Chlamydia pneumoniae, Mycoplasma pneumoniae, and Ureaplasma urealyticum is similar to or slightly stronger than that of erythromycin. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the transfer of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. |
80214-83-1 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acanthopanax Root-Bark Extract |
Replenishing Qi and strengthening the spleen, nourishing the kidney and calming the mind
More
Replenishing Qi and strengthening the spleen, nourishing the kidney and calming the mind |
0 |